| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18505968 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 253 journal articles in the PubMed database | Email to a friend | | |
| Martín M, Rodríguez-Lescure A, Ruiz A, et al.
Randomized phase 3 trial of Fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer. [Journal Article, Research Support, Non-U.S. Gov't]
J Natl Cancer Inst 2008 Jun 4; 100(11):805-14.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Venturini M, Del Mastro L, Aitini E, et al.
Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial. [Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Natl Cancer Inst 2005 Dec 7; 97(23):1724-33.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Francis P, Crown J, Di Leo A, et al.
Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial. [Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
J Natl Cancer Inst 2008 Jan 16; 100(2):121-33.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Konecny GE, Thomssen C, Lück HJ, et al.
Her-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer. [Journal Article]
J Natl Cancer Inst 2004 Aug 4; 96(15):1141-51.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Lee KH, Im SA, Oh DY, et al.
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as an adjuvant chemotherapy. [JOURNAL ARTICLE]
BMC Cancer 2007 Apr 12; 7(1):63.
Abstract | Full Citation | | Goss PE, Ingle JN, Martino S, et al.
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. [Clinical Trial, Journal Article, Randomized Controlled Trial]
J Natl Cancer Inst 2005 Sep 7; 97(17):1262-71.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Quintela-Fandino M, López JM, Hitt R, et al.
Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support. [Journal Article]
J Clin Oncol 2006 Aug 1; 24(22):3611-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Roché H, Fumoleau P, Spielmann M, et al.
Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial. [Journal Article, Research Support, Non-U.S. Gov't]
J Clin Oncol 2006 Dec 20; 24(36):5664-71.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Fisher B, Jeong JH, Anderson S, et al.
Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials. [Clinical Trial, Journal Article, Randomized Controlled Trial]
J Natl Cancer Inst 2004 Dec 15; 96(24):1823-31.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
